- トップ
- 研究業績
- Kurosawa S, Yamaguchi H, Yamaguchi T, Fukunaga K, Yui S, Kanamori H, Usuki K, Uoshima N, Yanada M, Takeuchi J, Mizuno I, Kanda J, Okamura H, Yano S, Tashiro H, Shindo T, Chiba S, Tomiyama J, Inokuchi K, Fukuda T. The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse. Int J Hematol 112(2):200-209, Aug, 2020 (doi: 10.1007/s12185-020-02894-x.) Epub Jun 3, 2020
Kurosawa S, Yamaguchi H, Yamaguchi T, Fukunaga K, Yui S, Kanamori H, Usuki K, Uoshima N, Yanada M, Takeuchi J, Mizuno I, Kanda J, Okamura H, Yano S, Tashiro H, Shindo T, Chiba S, Tomiyama J, Inokuchi K, Fukuda T. The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse. Int J Hematol 112(2):200-209, Aug, 2020 (doi: 10.1007/s12185-020-02894-x.) Epub Jun 3, 2020
2020/12/28
- 研究業績
- Kurosawa S, Yamaguchi H, Yamaguchi T, Fukunaga K, Yui S, Kanamori H, Usuki K, Uoshima N, Yanada M, Takeuchi J, Mizuno I, Kanda J, Okamura H, Yano S, Tashiro H, Shindo T, Chiba S, Tomiyama J, Inokuchi K, Fukuda T. The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse. Int J Hematol 112(2):200-209, Aug, 2020 (doi: 10.1007/s12185-020-02894-x.) Epub Jun 3, 2020
« Fujita H, Ishikawa Y, Yokoyama Y. JSH practical guidelines for hema... | Miyoshi H, Sakata-Yanagimoto M, Shimono J, Yoshida N, Hattori K, Ar... »
